89 related articles for article (PubMed ID: 2043481)
1. Terminal transferase expression in acute myeloid leukaemia: biology and prognosis.
Gucalp R; Paietta E; Weinberg V; Papenhausen P; Dutcher JP; Wiernik PH
Br J Haematol; 1991 May; 78(1):48-54. PubMed ID: 2043481
[TBL] [Abstract][Full Text] [Related]
2. P-glycoprotein and terminal transferase expression identify prognostic subsets within cytogenetic risk classes in acute myeloid leukemia.
Del Poeta G; Venditti A; Stasi R; Aronica G; Cox MC; Buccisano F; Tamburini A; Bruno A; Maurillo L; Battaglia A; Suppo G; Epiceno AM; Del Moro B; Masi M; Amadori S; Papa G
Leuk Res; 1999 May; 23(5):451-65. PubMed ID: 10374859
[TBL] [Abstract][Full Text] [Related]
3. Lymphoid lineage-associated features in acute myeloid leukaemia: phenotypic and genotypic correlations.
Paietta E; Van Ness B; Bennett J; Racevskis J; Gucalp R; Cassileth P; Wiernik PH
Br J Haematol; 1992 Oct; 82(2):324-31. PubMed ID: 1419814
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of terminal transferase (TdT) in acute lymphocytic leukaemia expressing myeloid antigens and TdT positive acute myeloid leukaemia as compared to myeloid antigen negative acute lymphocytic leukaemia.
Paietta E; Racevskis J; Bennett JM; Wiernik PH
Br J Haematol; 1993 Jul; 84(3):416-22. PubMed ID: 8217792
[TBL] [Abstract][Full Text] [Related]
5. The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukemia.
Lee EJ; Yang J; Leavitt RD; Testa JR; Civin CI; Forrest A; Schiffer CA
Leukemia; 1992 Nov; 6(11):1203-9. PubMed ID: 1279324
[TBL] [Abstract][Full Text] [Related]
6. Prognostic relevance of the expression of Tdt and CD7 in 335 cases of acute myeloid leukemia.
Venditti A; Del Poeta G; Buccisano F; Tamburini A; Cox-Froncillo MC; Aronica G; Bruno A; Del Moro B; Epiceno AM; Battaglia A; Forte L; Postorino M; Cordero V; Santinelli S; Amadori S
Leukemia; 1998 Jul; 12(7):1056-63. PubMed ID: 9665190
[TBL] [Abstract][Full Text] [Related]
7. Terminal transferase positive acute myeloid leukemia: immunophenotypic characterization and response to induction therapy.
Lo Coco F; Lopez M; Pasqualetti D; Montefusco E; Cafolla A; Monarca B; Sgadari C; De Rossi G
Hematol Oncol; 1989; 7(2):167-74. PubMed ID: 2646199
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
[TBL] [Abstract][Full Text] [Related]
9. Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers.
Adriaansen HJ; Jacobs BC; Kappers-Klunne MC; Hählen K; Hooijkaas H; van Dongen JJ
Leukemia; 1993 Mar; 7(3):472-81. PubMed ID: 7680403
[TBL] [Abstract][Full Text] [Related]
10. The value of detecting surface and cytoplasmic antigens in acute myeloid leukaemia.
Urbano-Ispizua A; Matutes E; Villamor N; Sierra J; Pujades A; Reverter JC; Feliu E; Cervantes F; Vives-Corrons JL; Montserrat E
Br J Haematol; 1992 Jun; 81(2):178-83. PubMed ID: 1322689
[TBL] [Abstract][Full Text] [Related]
11. CD7 expression in acute myeloid leukemia.
Del Poeta G; Stasi R; Venditti A; Cox C; Aronica G; Masi M; Bruno A; Simone MD; Buccisano F; Papa G
Leuk Lymphoma; 1995 Mar; 17(1-2):111-9. PubMed ID: 7539657
[TBL] [Abstract][Full Text] [Related]
12. Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies.
Haferlach T; Schoch C; Löffler H; Gassmann W; Kern W; Schnittger S; Fonatsch C; Ludwig WD; Wuchter C; Schlegelberger B; Staib P; Reichle A; Kubica U; Eimermacher H; Balleisen L; Grüneisen A; Haase D; Aul C; Karow J; Lengfelder E; Wörmann B; Heinecke A; Sauerland MC; Büchner T; Hiddemann W
J Clin Oncol; 2003 Jan; 21(2):256-65. PubMed ID: 12525517
[TBL] [Abstract][Full Text] [Related]
13. TdT+/nonlymphoid antigen+ acute leukemias: immunologic and karyotypic monitoring during therapy and at relapse suggests the transformation of a bipotential stem cell.
Paietta E; Gucalp R; Papenhausen P; Dutcher JP; Wiernik PH
Leukemia; 1989 Jul; 3(7):485-91. PubMed ID: 2733453
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of karyotype and immunologic phenotype in 125 adult patients with de novo AML.
Marosi C; Köller U; Koller-Weber E; Schwarzinger I; Schneider B; Jäger U; Vahls P; Nowotny H; Pirc-Danoewinata H; Steger G
Cancer Genet Cytogenet; 1992 Jul; 61(1):14-25. PubMed ID: 1638477
[TBL] [Abstract][Full Text] [Related]
15. Light scatter characteristics of blast cells in acute myeloid leukaemia: association with morphology and immunophenotype.
Vidriales MB; Orfao A; López-Berges MC; González M; López-Macedo A; García MA; Galende J; San Miguel JF
J Clin Pathol; 1995 May; 48(5):456-62. PubMed ID: 7629293
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies in myeloid diseases: prognostic use in acute myeloid leukaemia.
Kristensen JS; Hokland P
Leuk Res; 1991; 15(8):693-700. PubMed ID: 1895750
[TBL] [Abstract][Full Text] [Related]
17. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA
Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
[TBL] [Abstract][Full Text] [Related]
18. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA
Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
[TBL] [Abstract][Full Text] [Related]
19. Relevance of immunophenotypes to prognostic subgroups of age, WBC, platelet count, and cytogenetics in de novo acute myeloid leukemia.
Li X; Li J; Du W; Zhang J; Liu W; Chen X; Li H; Huang S; Li X
APMIS; 2011 Jan; 119(1):76-84. PubMed ID: 21143529
[TBL] [Abstract][Full Text] [Related]
20. Terminal deoxynucleotidyl transferase expression in acute myelogenous leukemia and myelodysplasia as determined by flow cytometry.
Huh YO; Smith TL; Collins P; Bueso-Ramos C; Albitar M; Kantarjian HM; Pierce SA; Freireich EJ
Leuk Lymphoma; 2000 Apr; 37(3-4):319-31. PubMed ID: 10752983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
